Free Subscription

  • Access daily briefings and unlimited news articles

Premium

Only $34.95 per year
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis

Australian Pharmaceutical Industries

Australian Pharmaceutical Industries Archives

ACCC clears the way for Wesfarmers to acquire Priceline parent

In talking with stakeholders, the ACCC found few concerns about potential market disruption because there are a large nu...

ACCC clears the way for Wesfarmers to acquire Priceline parent

In talking with stakeholders, the ACCC found few concerns about potential market disruption because there are a large nu...

Woolworths pulls bid to pick up pharmacy group API

Woolworths said it was unable to validate the financial returns it would require from the acquisition after completing i...

“We are not here to disrupt the sector”: Woolies’ case to pharmacists

Woolies chief executive Brad Banducci has penned an open letter to Australian pharmacists outlining the supermarket grou...

Wesfarmers moves to block Woolies’ bid for API

According to Wesfarmers, a growing number of pharmacists and chemists find the overlap between Woolworths’ products and ...

Woolies blocks Wesfarmers’ plans for API with $872 million bid

According to Woolworths, API’s board has determined their proposal is likely to be superior to Wesfarmers’, and it is wo...

Rival pharmaceutical company seeks to keep API from Wesfarmers

Sigma Healthcare looks to sweep up its rival before Wesfarmers can create its new division.

Wesfarmers makes revised bid for Priceline-owner

API's board is recommending shareholders back the revised offer, which will now see them paid out at a 37 per cent premi...

API commits to major NSW distribution centre

Australian Pharmaceutical Industries will construct a new 32,506sqm NSW distribution centre at Marsden Park to improve i...

Priceline benefits from timely e-commerce launch

Demand for Priceline's Click & Collect and Click & Deliver soars during the pandemic.

Priceline Pharmacy sales lift 2.4 per cent to $2.2 billion

API reports $4.0 billion in revenue for FY19 as flagship health and beauty retailer sees like-for-like sales return to g...

API banks on its own “growth engines” after Sigma merger taken off the table

CEO Richard Vincent said API is no rush to sell its Sigma shares.

API offers $727m for Sigma Healthcare

Drug distributor plans to buy its rival in the face of increased competitive and regulatory pressures.

This week in FMCG

In the headlines this week.

Priceline owner flags record half-year

The group will soon have 462 stores.

API flags profit lift

Australian Pharmaceutical Industries expects to lift underlying profit despite a tough retail environment.